CerebrAlcare Pills on CereBral Small VesseL DiseasE(CABLE)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 114 participants.

Also called NCT05578521

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 114 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05578521
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05578521. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-05 (actual); primary completion 2023-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
CerebrAlcare Pills on CereBral Small VesseL DiseasE(CABLE)
Condition
Cerebral Small Vessel Diseases
Intervention (Drug)
Cerebralcare pills
Intervention (Drug)
Cerebralcare pills placebo
Lead sponsor
Beijing Tiantan Hospital (class: other)
Collaborator
Tasly Pharmaceutical Group Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct05578521
Content hash
139b280e27176bf06d2c4b75cbd1206845c829f4621ec47227d9537ea1e1a7ed